Who owns the EVEREST MEDICINES trademark?

The EVEREST MEDICINES trademark is owned by Everest Medicines (Singapore) Pte. Ltd..

What class is the EVEREST MEDICINES trademark registered in?

The EVEREST MEDICINES trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for EVEREST MEDICINES?

The USPTO serial number for EVEREST MEDICINES is 98977528.

What is the registration number for EVEREST MEDICINES?

EVEREST MEDICINES is registered under USPTO registration number 8441611.

EVE

USPTO Trademark Record

REGISTERED

EVEREST MEDICINES

SN 98977528·Reg 8441611·Filed Feb 22, 2024

Owner Everest Medicines (Singapore) Pte. Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

EVEREST MEDICINES (Serial No. 98977528), Registration No. 8441611, is a registered US trademark filed on Feb 22, 2024 by Everest Medicines (Singapore) Pte. Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: September 15, 2032

Mark Intelligence

EVEREST MEDICINES (Reg. #8441611) is a registered US trademark that has been protecting its owner, Everest Medicines (Singapore) Pte. Ltd., since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 22, 2024

SERIAL

98977528

REG#

8441611

REGISTERED

Sep 15, 2026

Owner

Applicant

Everest Medicines (Singapore) Pte. Ltd.

Entity

Limited (UK / Scandinavian)

Address

30 Cecil Street #19-08 Prudential Tower, Singapore, 049712

Country

Attorney

NameKhanh T. Glatzel

Law firm

Khanh T. Glatzel Rimon, P.C.

Docket

EM Word(US)

Address

440 Stevens Ave., Suite 200, Solana Beach, CA 92075, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 22, 2024

Serial Number98977528

Registration No.8441611

Registration DateSep 15, 2026

Status DateSep 15, 2026

Published for OppositionDec 17, 2024

Mark TypeStandard characters

Attorney DocketEM Word(US)

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Feb 20, 2025

First use in commerce: Feb 20, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

38 events

REGISTERED-PRINCIPAL REGISTER

Sep 15, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 15, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ASSIGNED TO LIE

Aug 27, 2026

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 27, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 27, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 27, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 27, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 24, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Apr 17, 2026

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Apr 17, 2026

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

DIVISIONAL PROCESSING COMPLETE

Feb 24, 2026

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Feb 24, 2026

STATEMENT OF USE PROCESSING COMPLETE

SU - NON-FINAL ACTION - WRITTEN

Feb 24, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Feb 24, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 24, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 13, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Aug 08, 2025

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Aug 08, 2025

SOU TEAS EXTENSION RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Aug 08, 2025

TEAS REQUEST TO DIVIDE RECEIVED

DIVISIONAL REQUEST RECEIVED

Aug 08, 2025

DIVISIONAL REQUEST RECEIVED

USE AMENDMENT FILED

Aug 08, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 17, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 17, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 11, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 20, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 20, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 19, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 19, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 24, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 24, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 24, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ASSIGNED TO EXAMINER

Sep 11, 2024

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Sep 11, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 11, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 11, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 28, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 22, 2024

NEW APPLICATION ENTERED

EVEREST MEDICINES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Everest Medicines (Singapore) Pte. Ltd.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Khanh T. Glatzel

Resources

Company